The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients

Study acronym: PIVD
StatusActive, Not Recruiting
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Mar 2027 → Jul 2027
See other at-risk trials from Terry Ponich

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting Show 5 more changesShow less
    • Primary and study completion pushed from Mar 2027 to Jul 2027
    • Start date changed from estimate of Oct 2025 to Nov 5, 2025
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site contact updated
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this clinical trial is to gain a better understanding of the effect of Vitamin D supplementation on disease activity and overall health. The main questions it aims to answer are: 1. What proportion of IBD patients adhere to Vitamin D supplement recommendations over a 12-month period? 2. Is the ASK-12 Questionnaire valid in measuring adherence among IBD patients? 3. Does the severity of a patient's Crohn's disease effect overall adherence, over a 12-month period? 4. Does the severity of a patient's Ulcerative Colitis disease effect overall adherence, over a 12-month period? 5. Does Vitamin D supplementation affect the health-related Quality of Life for IBD patients? 6. Is 2,000 IU/Day an effective dose to sustain appropriate blood Vitamin D levels among previously Vitamin deficient IBD patients? Participants will: * Take 2000 IU of Vitamin D every day for the next 12 months * Complete 2 surveys, bloodwork and a fecal calprotectin test at the initial, visit, 6 month follow up and 12 month follow up
Trial Details
NCT Number NCT07177157
Lead Sponsor Terry Ponich
Conditions
(from sponsor)		 Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease), Crohn Disease (CD)
Related terms Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov